Prion and leukocyte filter

0

Intravenous products: News-Medical.net report “Pall Corporation, a global leader in filtration, separation and purification, today announced the launch of the Leukotrap® Affinity Plus Prion and Leukocyte Reduction Filter System. The new blood filter reduces prions and leukocytes in a single step. The Leukotrap® Affinity Plus System is CE marked in accordance with requirements set out in the Medical Devices Directive (93/42/EEC).

Infectious prions (PRPsc) are known to be the causative agent of variant Creutzfeldt-Jakob disease (vCJD). The Pall Leukotrap Affinity Plus System reduces PRPSC prion by >3 LOG on average, based on Western blot methodology. As a primary leukocyte and prion reduction technology, it also facilitates superior hemoglobin recovery, to meet current EU requirements.”

Click here for the full story.


Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.